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To my beloved family
PROLOGUE
Halfway through my residency in child and youth psychiatry, I longed to obtain more insights
into the determinants of mental health problems than my residency could provide.
Consequently, I was introduced to my current research supervisors Cecilia Magnusson,
Christina Dalman and Clara Hellner-Gumpert. Our collaboration resulted in a project
exploring mental health service use in a health care register in Stockholm. Eventually, this
register was merged with a number of other health and administrative registers as part of the
Stockholm Youth Cohort, on which the studies in the present thesis are based. At the same
time, I enrolled as a Ph.D. student at Karolinska Institutet with a project plan focusing on
neurodevelopmental disorders.
Thanks to endless support from my research and clinical supervisors as well as colleagues, I
had the privilege of combining patient-oriented clinical practice with scientific training
throughout my Ph.D. studies. My current clinical work involves diagnostic ascertainment of
young children with suspected developmental disorders, such as autism spectrum disorders.
Thus, my clinical work is closely related to the research domains of this thesis, i.e.
ascertainment, recent prevalence changes of and risk factors for autism spectrum disorders.
I am grateful for the opportunity to work with patients as well as with colleagues who have
always strived to achieve an interactive flow of ideas between clinical work and research
domains. In light of the complexity of autism spectrum disorders, I believe that continuous
communication between these domains is necessary for the generation of research hypotheses
and the integration of new knowledge into clinical practice. Therefore, I hope that other
clinicians as well as myself will have further possibilities to combine clinical work and
research.
Stockholm, February 2015.


5ABSTRACT
The overall objective of this thesis is to estimate recent changes in and current prevalence of
autism spectrum disorders (ASD) among young people in Stockholm County. An additional
objective is to explore potential risk factors for ASD in view of the increasing occurrence in
the population. For this purpose, a register-based total population study was set up and ASD
case ascertainment validated as a means and research model for achieving the overall
objective.
All studies were based on the Stockholm Youth Cohort (SYC), a longitudinal total population
study of 0-17 year olds resident in Stockholm County at any time since 2001. Prospectively
compiled data for this population were merged from regional and national registers. In study
I, we found that 96.0% of clinical case notes from randomly sampled ASD cases in the SYC
were consistent with a diagnosis of ASD. Furthermore, we confirmed ASD in 82.5% of
affected twins in the SYC by means of cross-validation against a twin study. In study II, we
reported that ASD prevalence at the end of 2011 was 1.5% among 0-27 year olds
(N=735,096), of whom 25.9% had a registered diagnosis of ID. The ASD prevalence was
highest among teenagers at 2.4%. The male: female prevalence ratio for ASD decreased with
age (from 3.3:1 among 0-12 year olds, to 1.9:1 among 18-27 year olds), particularly for ASD
without ID. Between 2001 and 2011, the prevalence of ASD increased almost 3.5 fold among
2-17 year olds, mainly due to an eightfold increase of ASD without ID. In contrast, the
prevalence of ASD with ID increased only slightly during this period.
The recent increase in ASD prevalence has attracted research interest toward risk factors for
ASD that have increased in a parallel manner, such as parental age and weight. In study III,
we found that higher parental age increased the risk of offspring ASD as well as stronger
parental age effects for ASD with, than without, ID. We found the risk of ASD to be greater
for offspring of older mothers than for those of older fathers. Furthermore, the paternal age
effect on ASD risk was only evident among offspring to mothers aged 35 years or younger,
while maternal age increased the risk of ASD regardless of paternal age. In the population-
based analysis of study IV, we found that maternal overweight increased the risk of ASD,
while no such effect was evident in the sibling analysis. In addition to the finding that too
much weight gain during pregnancy increases the risk of offspring ASD, this study was the
first to report that too little weight gain also constitutes a risk.
In conclusion, the prevalence of identified ASD without comorbid ID has increased
substantially between 2001 and 2011 in Stockholm, and ASD currently affects more than 2%
of teenagers, with important implications for the planning of health and educational services.
Changes in diagnostic practice and awareness are likely to be the main drivers of the rise, but
an actual true increase in ASD incidence cannot be ruled out. Collectively, these studies
confirm the relevance of categorizing ASD according to ID. Finally, the SYC, with its
extensive register-based data as well as a valid and thorough ASD case ascertainment
constitutes an important resource for ASD research.
6LIST OF SCIENTIFIC PAPERS
I. Idring Selma, Rai Dheeraj, Dal Henrik, Dalman Christina, Sturm Harald, Zander
Eric, Lee Brian K, Serlachius Eva, Magnusson Cecilia
Autism spectrum disorders in the Stockholm Youth Cohort: design, prevalence and
validity.
PLoS One. 2012;7(7):e41280.
II. Idring Selma, Lundberg Michael, Sturm Harald, Dalman Christina, Gumpert Clara,
Rai Dheeraj, Lee Brian K, Magnusson Cecilia
Changes in prevalence of Autism Spectrum Disorders in 2001-2011: findings from
the Stockholm Youth Cohort.
Journal of Autism and Developmental Disorders, 2014, Epub ahead of print.
III. Idring Selma, Magnusson Cecilia, Lundberg Michael, Ek Mats, Rai Dheeraj,
Svensson Anna C, Dalman Christina, Karlsson Håkan, Lee Brian K
Parental age and the risk of autism spectrum disorders: findings from a Swedish
population-based cohort.
International Journal of Epidemiology, 2014, 43 (1), 107-115.
IV. Gardner Renee M., Lee Brian K., Magnusson Cecilia, Rai Dheeraj, Frisell Thomas,
Karlsson Håkan, Idring Selma, Dalman Christina
Maternal body mass index during early pregnancy, gestational weight gain, and risk
of autism spectrum disorders: Results from a Swedish total population and discordant
sibling study.
Manuscript submitted.
7TABLE OF CONTENTS
1 BACKGROUND...........................................................................................................10
1.1 Diagnostic classification of ASD........................................................................10
1.2 ASD case ascertainment methodology ...............................................................14
1.2.1 Case definition.........................................................................................14
1.2.2 Case identification...................................................................................14
1.2.3 Case confirmation ...................................................................................15
1.3 ASD prevalence...................................................................................................15
1.3.1 ASD prevalence in relation to socio-demographic characteristics ........16
1.3.2 Time trends in ASD occurrence .............................................................16
1.4 Risk factors for ASD ...........................................................................................16
1.4.1 Parental age .............................................................................................17
1.4.2 Maternal BMI and gestational weight gain ............................................18
2 AIMS OF THE THESIS ...............................................................................................20
2.1 Overall hypotheses ..............................................................................................20
2.2 Specific aims........................................................................................................20
2.2.1 Study I......................................................................................................20
2.2.2 Study II ....................................................................................................20
2.2.3 Study III...................................................................................................20
2.2.4 Study IV...................................................................................................20
3 MATERIALS AND METHODS .................................................................................22
3.1 The Stockholm Youth Cohort .............................................................................22
3.2 Register linkage in the Stockholm Youth Cohort...............................................22
3.3 Services for individuals with ASD in Stockholm...............................................25
3.4 ASD cases in the Stockholm Youth Cohort .......................................................26
3.5 Exposure variables...............................................................................................26
3.5.1 Maternal and paternal age.......................................................................26
3.5.2 Maternal and paternal BMI, gestational weight gain and metabolic
conditions ................................................................................................26
3.6 Statistical analyses...............................................................................................27
3.6.1 Inferential statistics .................................................................................27
3.6.2 Estimation of inter-rater agreement ........................................................27
3.6.3 Regression methods ................................................................................27
3.7 Ethical approval...................................................................................................28
3.8 Study I methods...................................................................................................29
3.8.1 Case-note review.....................................................................................29
3.8.2 Cross-validation against a twin study.....................................................30
3.9 Study II methods..................................................................................................30
3.10 Study III methods ................................................................................................30
3.11 Study IV methods ................................................................................................31
3.11.1 Maternal and paternal BMI, maternal metabolic conditions .................31
3.11.2 Gestational weight gain...........................................................................31
83.11.3 Sibling analyses.......................................................................................31
3.11.4 Sensitivity analyses .................................................................................32
4 RESULTS......................................................................................................................33
4.1 Study I: Year 2007 ASD prevalence and validation of ASD case
ascertainment .......................................................................................................33
4.2 Study II: ASD prevalence in 2011 and changes in ASD prevalence 2001-
2011......................................................................................................................35
4.3 Study III: Parental age and risk of offspring ASD .............................................38
4.4 Study IV: Maternal BMI, gestational weight gain and risk of offspring
ASD .....................................................................................................................38
5 DISCUSSION ...............................................................................................................39
5.1 Key findings in relation to current knowledge ...................................................39
5.1.1 Case definition.........................................................................................39
5.1.2 Case identification...................................................................................39
5.1.3 Validation of ASD case ascertainment...................................................39
5.1.4 Current ASD prevalence .........................................................................40
5.1.5 Recent changes in ASD prevalence........................................................41
5.1.6 Parental age and risk of offspring ASD..................................................42
5.1.7 Maternal BMI, gestational weight gain and risk of offspring ASD ......43
5.2 Methodological considerations ...........................................................................44
5.2.1 Study design ............................................................................................44
5.2.2 Random error...........................................................................................45
5.2.3 Systematic error.......................................................................................45
5.2.4 Power .......................................................................................................47
5.2.5 External validity / generalizability..........................................................47
6 CONCLUDING REMARKS AND FUTURE DIRECTIONS ...................................49
7 CONCLUSIONS...........................................................................................................50
8 ACKNOWLEDGEMENTS..........................................................................................51
9 REFERENCES..............................................................................................................53
9ABBREVIATIONS
ASD Autism Spectrum Disorders
BMI Body Mass Index
CATSS The Child and Adolescent Twin Study in
Sweden
CDC Centers for Disease Control and Prevention
DSM Diagnostic and Statistical Manual of
Psychiatric Disorders
GAM General Additive Model
GWG Gestational Weight Gain
ICD International Classification of Diseases
ID Intellectual Disability
IQR Interquartile Range
MBR Medical Birth Register
NPR National Patient Register
PDD Pervasive Developmental Disorders
PIN Personal Identification Number
SYC Stockholm Youth Cohort
TPR Total Population Register
10
1 BACKGROUND
Autism spectrum disorders (ASD) are neurodevelopmental conditions characterized by
impaired social interaction and communication, as well as restricted/ repetitive behaviours.
As the name suggests, these core symptoms range on a spectrum from mild to severe. ASD
are behaviourally defined, implying that a diagnosis is based on the symptoms presented by
an individual, rather than on objective biological measures such as blood tests and
radiological examinations. A diagnosis of ASD does not pertain to the cause or aetiological
mechanism of the disorder. At present, such a diagnosis is defined by specific diagnostic
criteria as set out in the International Classification of Diseases (ICD) (1) and the Diagnostic
and Statistical Manual of Mental Disorders (DSM) (2, 3). To qualify for a diagnosis of ASD,
an individual’s daily functioning must be limited by her/ his symptoms. While the first signs
of ASD commonly emerge early in early childhood and a reliable diagnosis can be made by
the age of two years (4, 5), there is vast variability in the time of diagnosis (6). Early
diagnosis is considered optimal as it enables early intervention, which has been found
beneficial for younger children (7, 8). However, in many individuals impairments related to
ASD – and hence the possibility of being diagnosed – first manifest when the demands of
social interaction and communication exceed her/ his abilities.
In addition to the core symptoms of ASD, a substantial proportion of affected individuals
present with comorbid conditions and/ or symptoms (9). Common comorbid conditions
related to cognitive development and behaviour include intellectual disability (ID), attention
problems, hyperactivity, aggression, depressive symptoms and sleep disorders (10).
Furthermore, many individuals with ASD also present with comorbid medical conditions
such as epilepsy and genetic disorders (11). The variable core symptoms of ASD, in
combination with the range of comorbid conditions contribute to the heterogeneous
manifestation. This presents an immense challenge in the field of ASD diagnostics,
interventions and research.
1.1 DIAGNOSTIC CLASSIFICATION OF ASD
More than 70 years have elapsed since Dr. Kanner’s milestone report on 11 children with
deviating social development. In the following years, the field of classification of what is now
known as ASD has undergone massive change. Initially considered a condition associated
with schizophrenia, autism became an independent diagnostic entity in the ICD and DSM in
1977 and 1980, respectively. At that point, autism was narrowly defined as “infantile autism”
in a class of disorders termed “pervasive developmental disorders” (PDD). In order to better
describe the heterogeneous manifestation of autism, the diagnoses within the PDD diagnostic
class have been progressively broadened in both the DSM and the ICD.
During the past two decades, the DSM-IV and the ICD-10 have been used to define PDD
subdiagnoses, which are strongly related in both manuals. The DSM-IV and the ICD-10
include a diagnosis covering a fulminant triad of core symptoms of ASD (impairments in
social interaction, communication, and restricted/ repetitive behaviours), entitled “Autistic
11
Disorder” in the DSM-IV and “Childhood Autism” in the ICD-10. Both also include the
diagnosis “Asperger’s Disorder (DSM-IV)/ Syndrome (ICD-10)”. Individuals who qualify
for the latter deviate in terms of social interaction and interests or behaviour but have neither
significant language delays nor cognitive impairments. The DSM-IV diagnosis “PDD – not
otherwise specified” encompasses individuals who do not meet the fulminant core symptoms
of Autistic Disorder /Childhood Autism, nor the diagnostic criteria for Asperger’s Disorder.
In the ICD-10 it corresponds to by several diagnoses with a more specific clinical
presentation - “Atypical Autism”, “Other PDD” and “PDD – unspecified”. In addition,
“Rett’s syndrome” and “Childhood Disintegrative disorder” are included in both manuals and
pertain to individuals with normal initial development, followed by the loss of previously
acquired skills within several developmental areas, including socio-communicative skills.
The DSM-IV diagnostic criteria for Autistic Disorder, Asperger’s Disorder, and PDD not
otherwise specified are listed in Box 1. While clinicians and researchers have used the
diagnostic subcategories of the DSM-IV and ICD-10 for the past two decades, the
distinctions between them have been found to be unreliable in several studies, providing little
clinical information (12-14). The alternative approach of subtyping ASD in relation to
comorbid ID is supported by recent clinical and population-based studies (12, 15, 16).
Because IQ tends to remain stable over time and is a robust predictor of outcome in ASD
(17), this method of ASD differentiation not only has practical implications for support and
management, but may also be more useful for aetiological investigations than the DSM-IV
and ICD-10 (15, 18).
In 2013, the most recent DSM revision, DSM-5, was published in the USA (3). At the time of
writing it has not been translated into Swedish and is not yet clinically used in Sweden. A
revised ICD-11 is due by 2017. The DSM 5 implies several major changes for the diagnosis
of autism and related conditions. Amongst other, the subcategories of PDD have been
replaced by a single, overarching category and ASD diagnosis. Because a distinct genetic
aetiology has been found for Rett’s syndrome and Childhood disintegrative disorder, these
are no longer listed under ASD. For a diagnosis of ASD in the DSM 5, an individual has to
have, or have had, socio-communicative impairments as well as restricted, repetitive patterns
of behaviour. Individuals with socio-communicative impairments but no repetitive and
behavioural symptoms are listed under the new diagnosis of “Social Communication
Disorder”. ASD is characterized by specifiers in the DSM 5, which relate to the presence of a
wide range of comorbid conditions including ID, language impairment and medical or
genetic factors (3).
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DSM-IV Diagnostic Criteria for Autistic Disorder
I. A total of six (or more) items from (1), (2), and (3), with at least two from (1), and one each from (2) and (3):
(1) Qualitative impairment in social interaction, as manifested by at least two of the following:
(a) Marked impairment in the use of multiple nonverbal behaviors such as eye to-eye gaze,
facial expression, body postures, and gestures to regulate social interaction .
(b) Failure to develop peer relationships appropriate to developmental level
(c) A lack of spontaneous seeking to share enjoyment, interests, or achievements with other
people (e.g., by a lack of showing, bringing, or pointing out objects of interest)
(d) Lack of social or emotional reciprocity
(2) Qualitative impairments in communication as manifested by at least one of the following:
(a) Delay in, or total lack of, the development of spoken language (not accompanied by an
attempt to compensate through alternative modes of communication such as gestures or
mime)
(b) In individuals with adequate speech, marked impairment in the ability to initiate or sustain a
conversation with others
(c) Stereotyped and repetitive use of language or idiosyncratic language
(d) Lack of varied, spontaneous make-believe play or social imitative play appropriate to
developmental level
(3) Restricted repetitive and stereotyped patterns of behavior, interests, and activities, as manifested by at
least one of the following:
(a) Encompassing preoccupation with one or more stereotyped patterns of interest that is
abnormal either in intensity or focus
(b) Apparently inflexible adherence to specific, nonfunctional routines or rituals
(c) Stereotyped and repetitive motor mannerisms (e.g., hand or finger flapping or twisting, or
complex whole-body movements)
(d) Persistent preoccupation with parts of objects
II. Delays or abnormal functioning in at least one of the following areas, with onset prior to age 3 years:
(1) Social interaction
(2) Language as used in social communication
(3) Symbolic or imaginative play
III. The disturbance is not better accounted for by Rett’s Disorder or Childhood Disintegrative Disorder
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Box 1: DSM-IV diagnostic criteria for autistic disorder, Asperger’s disorder and PDD- not otherwise specified
DSM-IV Diagnostic Criteria for Asperger’s Disorder
I. Qualitative impairment in social interaction, as manifested by at least two of the following:
(a) Marked impairment in the use of multiple nonverbal behaviors such as eye-to-eye gaze, facial
expression, body postures, and gestures to regulate social interaction
(b) Failure to develop peer relationships appropriate to developmental level
(c) A lack of spontaneous seeking to share enjoyment, interests, or achievements with other people (e.g.,
by a lack of showing, bringing, or pointing out objects of interest to other people)
(d) Lack of social or emotional reciprocity
II. Restricted repetitive and stereotyped patterns of behavior, interests, and activities, as manifested by at
least one of the following:
(a) Encompassing preoccupation with one or more stereotyped and restricted patterns of interest that is
abnormal either in intensity or focus
(b) Apparently inflexible adherence to specific, non-functional routines or rituals
(c) Stereotyped and repetitive motor mannerisms (e.g., hand or finger flapping or twisting, or complex
whole-body movements)
(d) Persistent preoccupation with parts of objects
III. The disturbance causes clinically significant impairment in social, occupational, or other important areas
of functioning.
IV. There is no clinically significant general delay in language (e.g., single words used by age 2 years,
communicative phrases used by age 3 years)
V. There is no clinically significant delay in cognitive development or in the development of age-appropriate
self-help skills, adaptive behavior (other than in social interaction), and curiosity about the environment in
childhood.
VI. Criteria are not met for another specific Pervasive Developmental Disorder or Schizophrenia.
DSM-IV Diagnostic Criteria for Pervasive Developmental Disorders – Not Otherwise Specified
This category should be used when there is a severe and pervasive impairment in the development of
reciprocal social interaction or verbal and nonverbal communication skills, or when stereotyped behavior,
interests, and activities are present, but the criteria are not met for a specific Pervasive Developmental
Disorder, Schizophrenia, Schizotypical Personality Disorder, or Avoidant Personality Disorder. For example,
this category includes “atypical autism”– presentations that do not meet the criteria for Autistic Disorder
because of late age of onset, atypical symptomatology, or sub-threshold symptomatology, or all of these.
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1.2 ASD CASE ASCERTAINMENT METHODOLOGY
Case ascertainment methodology is a central aspect of ASD research. Studies on, e.g., ASD
prevalence, risk factors, treatment and outcomes should be compared in the light of how ASD
cases are defined, identified and confirmed in each study.
1.2.1 Case definition
Studies on ASD have used various case definitions, commonly restricting cases to the
diagnosis of autistic disorder/ childhood autism, or investigating various diagnostic
subcategories of PDD in accordance with the DSM-IV and ICD-10 or earlier versions. Case
definitions in other studies have encompassed a broader spectrum of ASD. A disadvantage
with this strategy is that it does not cover the behavioural and comorbid heterogeneity of
ASD unless cases are subcategorized.
1.2.2 Case identification
Two different principal strategies are used to identify individuals with ASD in a population;
1) the multistage approach, implying active screening of the study population with
subsequent diagnostic evaluation of screen-positive individuals, and 2) locating previously
identified cases.
1.2.2.1 The multistage approach
The first, population-screening phase of the multistage approach can involve administering
questionnaires pertaining to ASD symptoms to parents or teachers (19-23), applying
screening approaches at developmental follow-ups at paediatric units (24-27) or using health-
(28, 29), school- (30) or multiple (31-34) data sources to identify individuals at risk of ASD.
The second stage aims to assess whether the symptoms of at-risk individuals identified in the
first screening phase correspond to a diagnosis of ASD. Although considered to provide the
most accurate prevalence estimates, studies using the multistage approach may be hampered
by non-complete coverage, e.g., screening that does not include the entire population. Many
multistage studies have instead been directed towards populations with a higher probability of
ASD such as individuals with special education needs, thus potentially introducing selection
bias. Only a few studies based on the multistage approach have evaluated the sensitivity of
the screening methodology, i.e. estimating the proportion of affected individuals in the
general population identified by the screening procedure (20, 22, 23, 33, 35). Prevalence
estimates from population screening approaches should therefore be considered as minimum
ASD prevalence figures (19, 26).
1.2.2.2 Locating previously identified cases
This strategy identifies previously diagnosed ASD cases from various surveillance systems,
databases and registers. Such studies frequently rely on healthcare registers (36-42) and/ or
education registers (42-44). While more time and cost effective than studies using the
multistage approach, the primary drawback of this strategy is that it underestimates the
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prevalence among individuals not previously identified. Moreover, not all individuals with
ASD receive a diagnosis in any one setting or are in touch with any given service at all times,
indicating the need for thorough coverage of registers and surveillance systems with which an
affected individual is likely to be in contact.
1.2.3 Case confirmation
This phase serves to confirm ASD in individuals identified as being at risk in the preceding
screening phase of multistage studies as well as to examine the accuracy of a diagnosis in a
sample of identified cases.
1.2.3.1 Case confirmation in multistage studies
In some multistage studies, at-risk individuals identified in the screening phase underwent
diagnostic evaluation to confirm ASD case status using more or less structured methods (20,
21, 23, 25, 26, 28, 29, 32, 35). Diagnostic instruments used in this phase of multistage studies
are of varying reliability and validity, while willingness on the part of the individual involved
to participate in diagnostic evaluations may be limited (45). In contrast, a standardized review
and scoring system based on case notes, rather than diagnostic evaluation, has been
developed to determine ASD case status for data collected in the screening phase of US
surveys of ASD prevalence (33).
1.2.3.2 Case confirmation in studies based on previously identified cases
According to a review of validity studies in psychiatric research, a uniform standard for
assessing the accuracy of register data such as ASD diagnoses does not exist (Byrne et al
2005). To date, studies have confirmed previously identified ASD cases through clinical
evaluation (40), diagnostic interviews with parents or caregivers (46), and clinical case-note
reviews (47, 48).
1.3 ASD PREVALENCE
Early studies of ASD prevalence (the proportion of individuals with ASD at one point in
time) focused primarily on the narrowly defined infantile autism, reporting it as a rare
condition (45). However, recent reviews revealed that evidence from prevalence studies from
different parts of the world indicates that the median estimated ASD prevalence is
approximately 0.6% (45, 49), making ASD one of the most prevalent neurodevelopmental
disorders. The range of ASD prevalence estimates reported by different studies is wide, likely
contributed to by differences in case ascertainment methodology (45, 49). The range of ASD
prevalence estimates reported by different studies is wide, likely due to differences in case
ascertainment methodology (49). While the highest ASD prevalence estimates to date were
reported by studies relying on the multistage approach, the lowest prevalence estimates came
from studies locating previously identified cases from registers (45). Similarly, the proportion
of ASD cases with intellectual impairment (IQ < 70) varies from 14.7% in a UK study based
on previously identified cases (42) to 68.2% in a US study from Atlanta comprising a
multistage case ascertainment approach (34).
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1.3.1 ASD prevalence in relation to socio-demographic characteristics
The male predominance in ASD prevalence is one of the most consistent research findings
with an average 4.2:1 male: female ratio (50). However, this ratio varies from 1.8: 1 in a
Finnish study (51) to 15.7:1 in a UK study (Baird et al 2000), both of which employed
multistage case ascertainment approaches. The mechanisms underlying the skewed sex ratio
in ASD prevalence are unknown to date; underlying biological sex differences and / or
ascertainment / diagnostic bias may contribute (52).
Multiple studies in the US have reported an association between offspring ASD and higher
parental socio-economic status, indicated by e.g., parental education and household income
(53-57). However, it has been suggested that this association is a result of socio-economic
disparity in access to care (55, 58-62), suggesting that the association between socio-
economic status and ASD is biased by such disparities. Such disparities are also thought to
partly contribute to the lower ASD prevalence among certain racial / ethnic and immigrant
populations observed in some studies (33, 54, 61, 63). However, evidence of an association
between race/ ethnicity, migration and ASD prevalence has been inconsistent, with no strong
proof of underlying biological causal pathways (45).
1.3.2 Time trends in ASD occurrence
Global prevalence estimates of ASD have increased over recent decades (49), even in studies
examining prevalence over shorter, more recent time frames (33, 64, 65). For example, the
ASD prevalence estimate among 8-year olds increased by 123% from 2002 to 2010 in the US
(33). Increases in the identified prevalence of ASD have been noted at all levels of
intellectual ability (Baird et al 2006), but have been more pronounced in those with an
average or above-average IQ (Elsabbagh 2012, Samuendsen et al 2013, CDC 2014).
Although evidence has been found for improved identification of specific subgroups such as
Hispanic and black children during recent years, disparities in ASD prevalence across ethnic
groups remain in the US (CDC 2014).
Both the incidence and the prevalence of ASD increases due to non-etiological factors that
affect case ascertainment, such as increased public awareness (66), changes in diagnostic
criteria and reporting practices (67), and younger age at diagnosis (68, 69). As these factors
are problematic to control in surveys estimating time trends, it remains unclear which
proportion of the increase in ASD occurrence is associated with non-etiological factors.
Evidence to date indicates that an actual increase of ASD occurrence cannot be ruled out
(Volkmar et al 2014).
1.4 RISK FACTORS FOR ASD
Similar to the field of classification, research on the aetiology of ASD has undergone
principal development since Kanner’s first publication on children with ASD symptoms. For
several decades, autism was believed to be a result of poor parenting and more specifically
the cold, destructive behaviour of “refrigerator mothers” (70). Bettelheim’s causal theory
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remained dominant until the 1970s when the pioneering twin study on ASD by Folstein and
Rutter provided the first evidence of genetic influences in the aetiology of autism (71). Since
then, the importance of the genetic contribution to ASD has been confirmed by multiple twin
studies (72) as well as studies of familial recurrence (73-75). Early twin studies have
suggested that genetic factors contribute to as much as 90% of the probability of autism (72).
Accordingly, much research on the aetiology of ASD has focused on genetic factors.
However, two recent large-scale studies based on twins in California (76) and extended
families in Sweden (75) found a considerably lower contribution of genetic factors, 38% and
50%, respectively. Consequently, these studies suggest that non-genetic or environmental
factors have a greater role in the risk of ASD than previously believed.
Because the first symptoms of ASD commonly appear during toddler years, environmental
factors acting during the pre- and/ or perinatal period may be of particular interest for further
aetiological research. The recent rise in ASD prevalence led researchers to focus on
environmental risk factors for ASD that increase in a parallel manner, such as childbearing
age in the Western world (77), and parental overweight (78).
1.4.1 Parental age
The association between parental age and risk of ASD in offspring has attracted much
research attention. This is since the well-established demographic shift towards older first-
time parenthood in developed countries (79) has been paralleled by trends of increasing ASD
prevalence during recent decades. To date, approximately 40 studies have been published on
the association between maternal and paternal age and ASD (80). While results of individual
studies are mixed, recent meta-analyses integrating results from multiple studies report an
independent association between offspring ASD and both paternal (81) and maternal age
(82). According to these meta-analyses, mothers aged 35 years and over had a 1.5 fold (95%
CI 1.1-1.9) higher odds of offspring ASD compared to mothers aged 25-29 years (82), while
fathers aged 40-49 years had a 1.8 fold (95% CI 1.5-2.1) higher risk of offspring ASD
compared with fathers under the age of 30 years (81). However, the mechanism underlying
the association between maternal and paternal age and ASD remains unknown.
According to a recent review (80), evidence from epidemiological and animal studies
suggests that different mechanisms may be responsible for maternal and paternal age effects
on ASD risk. Current main hypotheses concerning paternal age effects on the risk of
offspring ASD are related to higher rates of de novo mutations and epigenetic alternations
with increasing paternal age. Similarly, structural and numerical genomic alternations with
increasing maternal age may contribute to ASD risk. Mothers may also increase the ASD risk
in offspring through age-related conditions such as perinatal and obstetrical complications
(83, 84), medications (85) and cumulative exposure to toxins (86, 87) – all of which have
been associated with greater ASD risk. Finally, ASD related personality traits and / or
psychiatric illness in parents may confound the association between advancing parental age
and offspring ASD through postponed parenting, an association which has been observed for
schizophrenia (88, 89). In conclusion, complex pathways including both genetic and non-
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genetic factors may underlie parental age effects on ASD risk, something that warrants
further research (80).
The associations between parental age and ASD have mainly been reported for various
diagnostic subtypes as presented in the DSM-IV or ICD-10 (82). However, as the diagnostic
reliability of these subtypes has been questioned, further examination of how parental age
affects different phenotypes of ASD is needed. For example, to date few studies have
investigated whether the associations between parental age and ASD differ in relation to
comorbid ID (90-93), and their results are inconsistent. Furthermore, there is a need for more
studies on how maternal and paternal age in relation to co-parental age affect the ASD risk.
For example, a recent Californian study indicated that the effect of advanced paternal age is
only apparent in younger mothers, while the maternal age effect on ASD risk was
independent of paternal age (94). Categorical parameterizations of parental age have been
used in most previous studies, which limit the full exploration of age effects (82). Finally,
most studies to date have provided relative risk estimates of parental age, which may be less
informative to the general public than absolute risk estimates (95).
1.4.2 Maternal BMI and gestational weight gain
Due to the substantial worldwide increase in overweight and obesity among children and
adults since the 1980s, obesity is currently a major global public health issue (78). In Sweden,
the proportion of women who were overweight or obese (i.e., BMI of 25 or more) at the first
antenatal visit increased from 25% in 1992 to more than 37% in 2009 (96). Maternal pre-
pregnancy overweight or obesity and excessive gestational weight gain (GWG) have well-
established associations with increased risk of several pregnancy-related and perinatal
complications, such as preeclampsia (97), gestational diabetes (98) and perinatal adverse
events (99). Moreover, associations between pre-pregnancy overweight and adverse
outcomes in offspring have been found, including congenital anomalies (100), as well as
cognitive and psychiatric problems (101).
Increased risk of offspring ASD has recently been associated with maternal pre-pregnancy
overweight/ obesity (58, 102, 103) and GWG (58, 103, 104). Nevertheless, the underlying
mechanisms of these associations remain unclear. Pregnancy-related and obstetric
complications associated with obesity may present a potential causal pathway, as they are
associated with offspring ASD (105-107). However, the association between maternal pre-
pregnancy overweight/ obesity and GWG may also be confounded by environmental,
lifestyle-related or genetic characteristics related to both these exposures, as well as offspring
ASD. Because such confounding factors are difficult to identify and measure, other analytical
approaches have been undertaken in recent studies in an attempt to untangle their role in the
association between pre-pregnancy weight, GWG and offspring ASD. For example,
individual associations between maternal and paternal BMI and offspring ASD can be
compared. Associations that are stronger for maternal than paternal BMI would be indicative
of causal intrauterine mechanisms. However, a recent study from Norway found paternal,
rather than maternal obesity to be associated with certain diagnostic subtypes of offspring
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ASD, which instead suggests a role of genetic factors (108). On the other hand, sibling
comparison designs can be used to control for genetic factors, as well as environmental
characteristics (e.g., socio-economic variables, rearing practices) that are similar among
siblings. If an association found at a population-level is attenuated when comparing siblings
with different exposures to pre-pregnancy BMI and GWG, it would indicate that there is an
environmental or genetic factors shared by siblings that confounds the population level
association. Only one study has examined the association between pre-pregnancy BMI and
GWG using the sibling comparison design. This study found that ASD risk was significantly
associated with GWG, but not pre-pregnancy BMI, both in a general population cohort and in
a sibling comparison study, indicating that there may be a causal intrauterine mechanism
related to GWG (104). All studies examining the association between pre-pregnancy BMI
and/or GWG and offspring ASD to date have included less than 1000 ASD cases, limiting
statistical power. In summary, the association between pre-pregnancy BMI, GWG and
offspring ASD needs to be examined in other populations taking unmeasured confounding
into account.
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2 AIMS OF THE THESIS
The overall aims of this thesis were to 1) establish a valid ASD case ascertainment method
using population registers 2) estimate recent changes in and current ASD prevalence, and 3)
explore the effects of parental age, maternal BMI in early pregnancy and GWG on risk of
offspring ASD with and without ID.
2.1 OVERALL HYPOTHESES
The overarching hypotheses tested in this thesis were:
1) That case ascertainment of individuals with ASD with and without ID would be valid
in a large population-based study using prospectively collected register data (i.e. the
Stockholm Youth Cohort)
2) That prevalence, changes in prevalence over time and risk factors and/ or the
magnitude of their associations with ASD may differ depending on comorbid ID
An overview of the research framework is presented in Figure 1.
2.2 SPECIFIC AIMS
More specifically, the studies aimed to investigate:
2.2.1 Study I
1) How ASD cases are defined and identified in Stockholm using prospectively collected data
from multiple registers, 2) whether ASD cases with and without comorbid ID in the
Stockholm Youth Cohort could be confirmed and 3) whether prevalence estimates of ASD
with and without comorbid ID in the SYC are similar to recent estimates from other
population-based studies.
2.2.2 Study II
Whether prevalence estimates of ASD had increased during a recent time period, and whether
the potential increase differed in relation to comorbid ID.
2.2.3 Study III
Whether greater maternal and paternal age had independent effects on the risk of offspring
ASD with and without comorbid ID, and whether such effects differ depending on co-
parental age.
2.2.4 Study IV
Whether maternal BMI in early pregnancy and GWG were associated with risk of offspring
ASD with and without comorbid ID. Furthermore, the study explored whether these
associations were affected by familial confounding.
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3 MATERIALS AND METHODS
3.1 THE STOCKHOLM YOUTH COHORT
All studies were based on the Stockholm Youth Cohort (SYC); a longitudinal total population
study of 0-17 year old individuals resident in Stockholm County at any time since 2001.
Prospectively collected data pertaining to this population were merged from national and
regional registers. On 31st December 2007 the SYC comprised 589,114 individuals (the
population used for studies I and III), while on 31st December 2011 this figure was 735,096
individuals (the population used for studies II and IV).
3.2 REGISTER LINKAGE IN THE STOCKHOLM YOUTH COHORT
Individuals in the SYC were identified by means of the Total Population Register,
maintained by Statistics Sweden (109). The unique identifier for an individual in this register
is a 10-digit personal identity number (PIN) that all Swedish citizens receive at birth. All
individuals who reside permanently in Sweden are also assigned a PIN. Immigrants without
permanent residency are instead assigned a coordination number and not registered in the
Total Population Register (110). The PIN is used in all contact with the public
administration, e.g., health care, education, and social services. The PIN also enables national
and regional registers to be merged, thus providing prospectively collected data on individual
characteristics. The national and regional registers used in the SYC are described in Table 1.
Individuals in the SYC were linked to their first degree relatives (adoptive and biological
parents and siblings) using the Multigeneration Register (111). Information on these relatives
was also retrieved from the different registers that constitute the SYC.
For the purpose of this thesis, data on socio-economic status including highest level of
educational attainment, occupational class and income were retrieved from the Integrated
database for Labour Market Research (112), while some older data on employment and
income were available from the National Population and Housing census (113). Individual
prenatal, delivery and neonatal data were collected from the Medical Birth Register (114,
115). Data on somatic and psychiatric outcomes were gathered from national and regional
health care registers, including the National Inpatient Register (116), Stockholm Adult
Psychiatric Care Register, Clinical Database for Child and Adolescent Psychiatry in
Stockholm, Habilitation Register and the VAL Database.
Additional register-based data from the SYC include information on prescribed drugs, sick-
leave, academic achievements, illness and disability pensions and criminal convictions, which
is available both for the index population and their first degree relatives.
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Register source (web site) Register
(coverage period)
Register contents
Statistics Sweden
(www.scb.se)
Total Population
Register (1968-)
(109)
Personal ID number, name, place of residence (region,
address), sex, age, civil / marital status (never married,
married, partner, divorced, widow/ widower), place of birth
(country, county, parish), citizenship, immigration (date,
country, ground for settlement), relations (married
couples, child-parent).
Multi-Generation
Register (1932-)
(111)
Linkages between individuals registered in Sweden at
any time since 1961, and born 1932 or later (index
persons), and their biological or adoptive parents.
Enables identification of full siblings, maternal and
paternal half siblings, children and cousins. Similar
information is available for immigrants to Sweden who
obtained Swedish citizenship before age 18 together with
one, or both parents. Biological father of a child is
assumed to be the husband of the mother at time of birth
or is identified by acknowledgement for unwed mothers.
National Population
and Housing
census (1960-
1990) (113)
Individual and household data for all Swedish residents
aged 16 years or older, e.g. employment, income,
housing, household size and type of household, provided
by the general public and real estate owners through
questionnaires at 5-year intervals.
Integrated
database for
Labour Market
Research
(LOUISE/ LISA)
(1990–) (112)
Integrates socio-economic data from the social insurance,
labour market and education sectors and is updated
annually. Provides individual data such as level of
education, employment including occupational class,
alternative employment (studies, labour market activities,
unemployment but also health insurance data such as
parental leave), disposable income, country of birth,
parental countries of birth, and latest year of immigration.
National School
Registers (1973-)
(117)
Subject-specific school leaving grades from compulsory-
(since 1988) and upper secondary school (since 1973) as
well as scores on subject-specific national tests in
compulsory school (since 2004)
The National Board of Health
and Welfare
(www.socialstyrelsen.se)
Medical Birth
Register (1973–)
(114, 115)
Data concerning prenatal-, delivery and neonatal care,
originating from compulsory reports by health care
providers. Includes prenatal characteristics recorded by
midwives (e.g. maternal weight and height at beginning
of the pregnancy, gestational weight gain, previous and
current maternal health including smoking and snuffing
habits, maternal medical drug use, diagnoses), delivery
characteristics (e.g. mode of delivery, birth presentation,
medication during delivery), and neonatal characteristics
(e.g. live- or stillbirth, duration of pregnancy, weight,
height, head circumference, APGAR score, birth weight
for gestational age). Potential ante- and perinatal
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complications are coded according to ICD 9–10.
National Patient
Register (1964–)
(116)
Data on admission / visit to health care service including
diagnoses coded according to ICD 7-10, and admission
date. Data covers inpatient care (with complete coverage
from psychiatric clinics from 1973, and complete national
coverage since 1987), and outpatient visits to specialist
doctors since 1997. Degree of coverage and content
varies depending on speciality.
Cancer Register
(1958–) (118)
Data concerning cancer site, histological type, stage, date
and basis of diagnosis, originating from compulsory
reports by health care providers. Classification and site of
tumors are coded according to ICD 7–10.
Cause of Death
Register (1952-;
1952-1960 of
varying quality;
(119, 120)
Includes data on primary and contributory causes of
death for all individuals who at the time of death were
registered Swedish residents. Causes of death are coded
according to ICD 7–10 and originate from the death
certificate, the reporting of which is compulsory for health
care providers. Primary and contributory causes of death
and date of death.
Prescribed Drug
Register (2005–)
(121)
Data on prescribed and administered drugs e.g. dosage.
Drugs are coded according to the national substance
classification system.
Stockholm County Council
(www.sll.se)
Stockholm Adult
Psychiatric Care
Register (1997–)
Adult psychiatric out- and inpatient care within Stockholm
County, including diagnosis and global assessment of
functioning ratings (GAF). Diagnoses are coded
according to DSM-IV groupings until 2004, and according
to the ICD 10 since 2005.
Clinical Database
for Child and
Adolescent
Psychiatry in
Stockholm (2001–)
Child and adolescent psychiatric in – and outpatient care
within Stockholm County, including diagnosis and ratings
of general functioning according to the Children’s Global
Assessment Scale. Diagnoses are coded according to
DSM-IV groupings until 2008, and according to ICD-10
since 2009.
Habilitation
Register (1997–)
Utilization of Stockholm County Habilitation Services
according to type of disability (ID, PDD, mobility, vision or
hearing impairments).
VAL database
(1997–) Public
health
Public health care services in Stockholm County,
including diagnostic (coded according to ICD 10,
available since 2006) and service provider (clinic)
information.
Swedish Social Insurance
Agency (www.fk.se)
Social Insurance
Registers (1994–)
Social insurance benefits including periods of sick leave
(with diagnostic information according to ICD 10 since
2005), disability pension (with diagnostic information
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according to ICD 9–10 since 1994), occupational injury
annuity, disability allowance, old age pension and
parental leave.
The Swedish Tax Agency
(www.skatteverket.se)
The Register of
Income and Wealth
(1968-1989)
Annual taxation data for the Swedish population
Swedish Defence
Recruitment Agency
The Conscription
Register
Data on physical and psychological characteristics for all
individuals born 1946 or later who enrolled or conducted
an entrance assessment at the Armed Forces’ Enrolment
Board or the National Service Administration. The archive
contains information on more than 3 million individuals.
Conscription at age 18-20 was mandatory for all Swedish
men until 2007; absence was punishable offence. In the
1990s, less than 5% did not enlist, usually due to somatic
illness or mental retardation.
The Swedish National Council
for Crime Prevention
(www.bra.se)
National
Convictions
Register (1973–)
(122)
Data on timing, nature and number of all offences that
lead to court convictions for individuals aged 15 or older.
Table 1: Overview of record-linkages to national and regional registers in the Stockholm Youth Cohort.
3.3 SERVICES FOR INDIVIDUALS WITH ASD IN STOCKHOLM
All services related to diagnostic ascertainment and follow-up, health care, special education
and social care are provided by services run or contracted by Stockholm County Council.
Individuals younger than 18 years are entitled to free non-emergency medical care (123).
Virtually all preschool children in Stockholm County are enrolled in the health- and
developmental surveillance programme provided by child healthcare centres in Stockholm
County (124), aimed at timely detection of developmental deviation such as cerebral paresis,
ID, ASD, and attention deficit/ hyperactivity disorder (125). As part of this programme, all
children are offered regular surveillance of social, motor, language and cognitive
development by specially trained nurses at 1, 2, 6, 10-12, 18, 36, 48 and 60 months of age.
Supplementary examinations by a medical doctor are provided at specific age points (2, 6,
10-12 months) and according to need or in cases of developmental deviation (124, 125).
In cases of suspected developmental deviation, children are referred to multi-professional
teams, typically including a psychologist and a medical doctor from the paediatric or child
mental health services (126). Children may also be referred to such teams by general
practitioners, child psychiatrists, speech therapists, school doctors as well as other health and
social agencies. Regional guidelines for diagnostic evaluation of neurodevelopmental
disorders, including ASD, ADHD, ID and borderline ID, were published by the Stockholm
County Council in 2010 (126) and diagnoses are in accordance with the DSM or ICD
classification system.
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If the diagnostic ascertainment results in a diagnosis of ASD, families are offered Habilitation
services for their child, usually at specialized Habilitation centres for children with ASD
(127). These services are not mandatory. Within the Habilitation services, various
interventions are offered according to individual need, including parental/ school staff
education, social care, intervention programmes and communication therapy.
3.4 ASD CASES IN THE STOCKHOLM YOUTH COHORT
The cases of ASD as of December 31st 2011 were collected from four national and regional
registers, covering all pathways of diagnosis and care related to ASD in Stockholm County.
The registers were (with the proportion of cases from each source in 2011 in parenthesis): 1)
the VAL database, a regional register providing data on public health care services in
Stockholm County (80.4%), 2) the Habilitation Register (69.4%), 3) the Clinical database for
Child and Adolescent Psychiatry in Stockholm (60.7%), and 4) the National Patient Register
(13.3%). A detailed description of the registers can be found in Table 1.
ASD was defined as a diagnosis of ICD-9 (299) or ICD-10 (F84) in the VAL database and the
National Patient Register and as a diagnosis of DSM-IV (299) in the Clinical database from
Child and Adolescent Psychiatry in Stockholm, while in the case of the Habilitation Register,
it was ascertained on the basis of registration as a service recipient in specialist ASD centres,
in which a formal ASD diagnosis is a prerequisite for referral. As information on DSM or
ICD diagnostic subcategories was not available in all registers, individuals with ASD were
divided into two groups based on the presence of comorbid ID (defined as IQ 70 and
functional impairment according to international and Swedish norms). ID was defined as a
recorded diagnosis of 317–319 or F70-79 based on the ICD-9 and ICD-10, respectively, or
317–319 according to the DSM-IV(1, 2), and supplemented by the Habilitation Register,
which categorizes service recipients as having autism with or without ID. Information about
the age at first diagnosis of an ASD was not available in these registers.
3.5 EXPOSURE VARIABLES
3.5.1 Maternal and paternal age
Maternal and paternal age was defined as the age of the biological mother and father at the
birth of the child. Parental age was retrieved from the MGR (111).
3.5.2 Maternal and paternal BMI, gestational weight gain and metabolic
conditions
Maternal BMI was derived from maternal weight and height data in the MBR recorded by
midwives at the first visit to a maternal health clinic at median 10.6 weeks of pregnancy (IQR
9.0-12.6) (115). Paternal BMI data were derived from the time of conscription in the Swedish
military at the age of 18-20 years, objectively measured by conscription personnel as part of
the physical examination. A weight below 40 kg and above 140 kg and a height under 140
cm and over 200 cm were censored. BMI values were categorized by standard convention
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(128): underweight (BMI<18.5), normal (18.5≤BMI<25), overweight (25≤BMI<30), and
obese (BMI≥30).
GWG was calculated for the mother/ child pairs for whom data on maternal weight was
available both at the first antenatal visit as well as at the time of delivery. GWG categories
were defined as “ideal”, “insufficient” or “excessive” for each BMI category (underweight:
12.5-18 kg, normal weight 11.5-16 kg, overweight 7-11.5 kg and obese 5.9 kg) as
recommended by the Institute of Medicine (129).
Maternal metabolic conditions (pre-gestational hypertension, pre-gestational diabetes, pre-
eclampsia, and gestational diabetes) were identified from the MBR or the NPR. Statistical
analysis
3.6 STATISTICAL ANALYSES
3.6.1 Inferential statistics
Inferential statistics are used to estimate the likelihood that chance alone accounts for the
observed results. One way of assessing the role of chance in observational studies is to
estimate the range of values likely to include the “true” value, i.e., the confidence interval.
The Clopper-Pearson method, based on cumulative probabilities of the binomial distribution,
was used to calculate the 95% confidence interval (CI) of the obtained proportion of ASD in
the study populations in studies I and II. In study III, a 95% CI was estimated from posterior
simulation of model parameters. Another way of assessing the role of chance in observational
studies is to use statistical tests to obtain a p-value, which is used to determine whether or not
results are accounted for by chance. To test the statistical significance of a difference in ASD
prevalence by sex and age in study I, the Chi square statistic was used, together with its
associated degrees of freedom, to derive a p-value. In study II, the 95% CIs of proportions
were compared to determine whether there were significant differences between different
groups from the study population.
3.6.2 Estimation of inter-rater agreement
In the case-note validation procedure in study I, Cohen’s kappa (K) coefficient was used as a
statistical measure of final case status concordance between the two reviewers. Cohen’s
kappa values are considered poor when < 0.0, slight at 0.0-0.2, fair at 0.21-0.4, moderate at
0.41-0.60, substantial at 0.61-0.8, and almost perfect to perfect at 0.81-1.00 (130).
3.6.3 Regression methods
Regression analysis includes all techniques for modelling and analysing the relationship
between a dependent (i.e., outcome) and an independent (i.e., predictor or exposure) variable.
The simplest form of regression analysis is linear regression, in which the relationship
between the outcome and predictor variables is linear. In this thesis, regression analyses were
used in Studies III and IV. Different types of regression analysis were applied depending on
the type of data.
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3.6.3.1 Logistic regression
Logistic regression is commonly used to analyse the relationship between a dichotomous
outcome (i.e., binary, meaning that it only has two outcomes, such as ASD yes /no) and a
number of exposures, while controlling for other confounding variables. Conditional logistic
regression is used when investigating this relationship in matched pairs, such as siblings in
Study IV. Logistic regression results in estimates of Odds Ratios (OR) with a 95% CI (the
odds of being affected by an outcome when exposed to a predictor, compared to those of
being affected by an outcome when not exposed to a predictor). Logistic regression is based
on an adaptation of ordinary linear regression.
3.6.3.2 General additive modelling (GAM)
While linear models offer a well-established framework for describing the relationship
between an exposure and outcome in epidemiological studies, they are limited by their
assumption of a linear correlation between these variables. In studies III and IV, we wished to
capture the shape of the association between the variables of interest and ASD without
suggesting that the relationship had a particular form prior to analysis. Cubic regression
splines in GAM provide such a framework, which is useful for modeling non-linear
relationships between variables. In short, an independent variable is divided into intervals
(cubic regression splines), which are used to obtain the best fit to the data. To avoid
overfitting the data, which weakens the predictive performance of a model, cubic regression
splines were penalized. Parental age, BMI and GWG estimates for the risk of ASD with and
without ID were presented as both continuous and categorical terms.
3.6.3.3 Accounting for clustered data
Individuals in the same family, e.g. siblings, are more similar to each other than individuals
from different family because of shared genetic and environmental factors. Consequently,
data collected on individuals from the same family (i.e., a cluster) are also more similar than
data on individuals from different families. Analysis of data consisting of multiple
observations on a cluster is complicated by within-cluster correlation. Within-cluster
correlation between exposures implies that disentangling individual contributions of an
exposure to an outcome may be impossible. Several methods can be used to account for
clustered data. In study III, GAM was adapted to account for clustering via random effects.
Hence, random effects for the birth mother were implemented in GAMs as penalized
regression terms, with smoothing parameter estimation by maximum likelihood. However, in
study IV, we used general estimating equation (GEE) models specifically developed for
clustered data, with the logit link clustered on the maternal identification number to provide
robust standard errors.
3.7 ETHICAL APPROVAL
Ethical approval for the record linkages and studies included in this thesis was provided by
the Research Ethics Committee at Karolinska Institutet. Informed consent was not required
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for the analysis of anonymized register data. Prior to researcher access to register data,
individual PINs are replaced by a unique identification code, which protects the personal
integrity of the individuals. For the clinical case-note review (Study I), randomly selected
individuals with ASD were de-identified by Statistics Sweden and their case notes scrutinized
by healthcare professionals bound by professional secrecy. Retrieved data were returned to
Statistics Sweden and the PINs replaced by unique identification codes. The results are
presented at group level.
3.8 STUDY I METHODS
The register linkage and ASD case ascertainment in the SYC was described in this paper.
Furthermore, the prevalence of ASD with and without ID in the year 2007 was estimated
for the study population (0-17 year olds resident in Stockholm County at some time between
2001 and 2007, N=589,114) as well as 95% confidence intervals for proportions. In order to
maximize the possibility of detecting an ASD diagnosis in the registers, only children
resident in Stockholm County for at least 4 years were included, resulting in a final study
population of 444,154 individuals. The overall prevalence of ASD as well as ASD with and
without ID was estimated for sex and age. These results were compared using the chi-square
statistic, while its associated degrees of freedom were employed to calculate the p-value.
ASD case ascertainment in the SYC was validated by means of two different approaches:
case-note review and cross-validation against the Child and Adolescent Twin Study in
Sweden (CATSS).
3.8.1 Case-note review
For the case-note review, a random sample of 100 ASD cases without, and 100 cases with,
comorbid ID was drawn from the SYC. Following ethical approval these individuals were de-
identified by Statistics Sweden, and their clinical case notes requested from the clinical units
responsible for their care. Using this process, clinical notes of 177 (88.5%) ASD cases were
retrieved, while the case notes of the remaining 23 ASD cases were either missing or could
not be retrieved due to lack of a response from the clinical units. Two clinical experts, a child
psychiatrist (Selma Idring) and a neuro-paediatrician (Anna Shchokina), reviewed the case
notes. A case note review survey was designed by a child psychiatrist (Selma Idring), a
neuro-paediatrician (Harald Sturm) and a medical doctor specialized in learning disabilities
(Dheeraj Rai), to be used during the review process. The survey covered documented
diagnoses, age at diagnosis and the diagnostic evaluation procedures used (in accordance with
regional guidelines published to date (126)). The latter included parental interviews, child
observation, psychometric and diagnostic tests and interviews, medical examination, and
complementary assessments. Moreover, all information on referrals to health and / or
community services related to ASD was retrieved. Of the 177 retrieved case notes, 74 were
reviewed independently by both assessors, blinded to each other. Inter-rater agreement was
calculated as Cohen’s kappa coefficient of the concordance of the final case status (overall
and by the presence of comorbid ID) between the reviewers. The criteria used to determine
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final case status were 1) a case-note documented diagnosis of ASD with or without ID in
accordance with ICD-9, ICD-10 or DSM-IV and at least one of the following, 2)
documented evidence of a structured diagnostic process, 3) evidence of referral to health-
and/or community services related to ASD with or without ID.
3.8.2 Cross-validation against a twin study
In the second approach, ASD cases from the SYC were compared with information from a
national population-based study of twins born since 1992 (the Child and Adolescent Twin
Study in Sweden- CATSS) (131). In CATSS, ASD was assessed via parental report, and a
comprehensive screening interview for a broad range of neurodevelopmental disorders was
conducted with the parents at the children’s 9th or 12th birthday (A-TAC), which is
considered a reliable and valid screening tool for ASD (132-134). All twins co-occurring in
the SYC and the CATSS were first identified, after which the proportion of SYC twins
confirmed as ASD cases in the CATSS was estimated.
3.9 STUDY II METHODS
In 2011 the ASD prevalence by comorbid ID and socio-demographic characteristics (age,
sex, country of origin, disposable family income at time of birth, highest level of parental
education) was estimated for the entire study population (0-17 year olds resident in
Stockholm County at some time between 2001 and 2011, N=735,096). The annual proportion
of ASD with and without ID among 2-17 year olds during the study period from 2001 up to
and including 2011 by birth year, sex, country of origin, disposable family income at time of
birth and highest level of parental education was calculated by dividing the number of cases
identified by the total number of residents at the follow-up at the end of 2011. The 95%
confidence intervals (CI) were calculated using the Clopper-Pearson method. The age range
of 2-17 years was selected because no cases were discovered among 0 to 1 year olds, while
estimates for adults during initial years of surveillance might be deflated by truncation, i.e.,
key registers for case ascertainment started in 1997 and 2001 could have deflated the
observed prevalence among older children.
3.10 STUDY III METHODS
Smoothing splines in GAMs were used to estimate the association between parental age and
ASD with and without ID in a sample of non-adopted individuals born between 1984 and
2003 who had resided in Stockholm County for at least four years and for whom there was
available data on maternal and paternal age (N=417,303). Models were adjusted for offspring
sex, birth year, co-parental age, parity, history of parental psychiatric care, occupational class,
family income and maternal country of birth. To account for clustering in sibships, random
effects for the birth mother were implemented in GAMs as penalized regression terms, with
smoothing parameter estimation by maximum likelihood. Maternal and paternal age
estimates of the risk of ASD with and without ID were presented as both continuous and
categorical terms. The prevalence of ASD with and without ID was also estimated for
maternal and paternal age categories.
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An interaction term for maternal and paternal age was introduced into the GAMs and the
statistical significance of the interaction tested using likelihood ratio to compare the models.
Furthermore, we conducted stratified analyses of maternal and paternal age in selected strata
of co-parental age.
3.11 STUDY IV METHODS
In this paper, the study population consisted of all 0-17 year olds in the SYC who had resided
in Stockholm for at least 4 years as of December 31, 2011 (N=735,096). Children who were
adopted (N=7,266), from a multiple birth (N=13,919) or born outside Sweden (N=60,020)
were excluded because no individual level data for maternal BMI and GWG were available
for them.
3.11.1 Maternal and paternal BMI, maternal metabolic conditions
Both categorical and continuous analyses were used to model the relationship between
maternal and paternal BMI and ASD. Restricted cubic spline models with 5 knots and
xbrcspline post-estimation were employed for continuous analyses, with BMI =21 as the
referent. General Estimating Equation (GEE) models with the logit link clustered on the
maternal identification number to provide standard errors were used to account for clustered
data. The models were adjusted for covariates chosen à priori, based on reported associations
with ASD including sex, birth year, parity, maternal age, paternal age, maternal country of
birth, parental education, income and parental psychiatric history (62, 81, 82, 85, 106) .
Maternal and paternal BMI were included separately and in a mutually adjusted model.
Analyses were performed for ASD, as well as for ASD with and without ID. GEE models
were used to estimate the relationship between maternal metabolic conditions and ASD. The
analyses were repeated including adjustment for each maternal BMI category.
3.11.2 Gestational weight gain
GWG was analysed as a categorical and continuous variable using GEE. Categorical analyses
employed ideal GWG as the referent category, while continuous analyses used restricted
cubic spline models with five knots and GWG=14 kg as the referent. In addition to adjusting
for sex, birth year, parity, maternal age, paternal age, maternal country of birth, parental
education, income and parental psychiatric history, the models were also adjusted for
maternal BMI category and gestational age at birth. Analyses were performed for ASD, as
well as for ASD with and without ID. The analysis was repeated in a restricted sample of
mothers who had a normal BMI at the start of pregnancy in order to distinguish potential
effects of GWG from BMI at the beginning of pregnancy.
3.11.3 Sibling analyses
The relationship between maternal BMI and ASD was analysed in matched sibling
comparisons using conditional logistic regression models, grouped on the maternal
identification number, and adjusted for sex, birth year, sibling birth order, as well as maternal
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and paternal age at time of birth. Maternal BMI was analysed both as a categorical and a
continuous variable for BMI values >= 21.
3.11.4 Sensitivity analyses
Sensitivity analyses were performed to examine the robustness of maternal and paternal BMI
effects. Maternal BMI was examined 1) in the full cohort with maternal BMI measures, 2) in
a sub-cohort with data on gestational week at the first visit 3) while controlling for a more
inclusive indicator of parental psychiatric illness including both in- and outpatient psychiatric
history and 4) while stratifying the sample on the median birth year 1997 in order to examine
cohort effects. For paternal BMI measures, sensitivity analyses included additional
adjustment for paternal IQ measured at the time of conscription, parental psychiatric service
use (in- or outpatient) and stratification on the median birth year (1997).
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4 RESULTS
4.1 STUDY I: YEAR 2007 ASD PREVALENCE AND VALIDATION OF ASD
CASE ASCERTAINMENT
A total of 5,100 cases of ASD (1.2%) were found in the study population of 4-23 year olds by
the end of 2007 (N=444,154). Of these, 42.6% (95% CI 41.0-44.2) also had a registered
diagnosis of ID. The prevalence of ASD increased with age, being lowest among 4-6 year
olds (0.7%; 0.6-0.7) and highest among 13-17 year olds (1.5%; 1.4-1.5). Among young adults
(18-23 years), ASD prevalence was 1.1% (1.0-1.1). (Fig. 2A).
The male: female prevalence ratio for ASD overall was 2.6:1, which was similar for ASD
with and without ID (2.7:1 versus 2.5:1). The sex ratio decreased with age (from 5.1:1 at age
8, to 1.9:1 at age 18), especially for ASD without ID (Fig. 2B, C).
The key findings of the validation studies of ASD case ascertainment in the SYC were that:
 A higher proportion of ASD cases without comorbid ID (77 out of 87, 88.5%) than
with comorbid ID (68 out of 90, 75.6%) was confirmed. Inter rater agreement on
ASD status was achieved in 71 of the 74 cases reviewed by both raters (corresponding
to a K of 0.91).
 From 148 clinical case notes providing detailed information about diagnostic
ascertainment, the median age at diagnosis was found to be 8.0 years for ASD overall
(range 1–19, interquartile range [IQR] 8.0), 11.5 years for ASD without ID (range 4–
19, IQR 6.0) and 6.0 years for ASD with ID (range 1–17, IQR 4.0) years. Girls were
older than boys at diagnostic assessment (median age 11.0 compared to 8.0 years).
The majority of cases had been evaluated by multidisciplinary teams in accordance
with current regional practice guidelines (126).
 Of the 27 twins with ASD identified in the SYC, 23 (85.2%, 66.2–95.8) had ASD
confirmed according to diagnostic information in the CATSS. Of the 2721 twins who
had not been identified with ASD in the SYC, a total of 27 (1.0%, 0.7–1.4) recieved
an ASD diagnosis in the CATSS.
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Figure 2. The prevalence of ASD in the Stockholm Youth Cohort in 2007.
Points indicate the observed prevalence (cases per 1,000) for each age (4-23 years). An empirical mode
decomposition smoothing curve is superimposed. A) ASD prevalence with or without comorbid ID B) ASD
prevalence according to sex C) ASD prevalence by sex with and without comorbid ID.
35
4.2 STUDY II: ASD PREVALENCE IN 2011 AND CHANGES IN ASD
PREVALENCE 2001-2011
A total of 11,330 cases of ASD (1.5%) were found in the study population of 0- 27 year olds
by the end of 2011 (N=735,096). Of these, 25.9% had a recorded diagnosis of ID. The ASD
prevalence in 2011 was found to be 0.4% (0.4-0.4), 1.7% (1.7-1.8), 2.4% (2.4-2.6), and 1.8%
(1.7-1.8) among 0-5, 6-12, 13-17, and 18-27 year olds, respectively. The corresponding
proportion of cases with a recorded diagnosis of ID was 17.4, 22.1, 26.1 and 29.4%.
The proportion of children identified as having ASD by the end of 2011 differed in terms of
the following socio-demographic characteristics:
 The male: female prevalence ratio for ASD overall was 2.3:1, which was similar for
ASD with and without ID. The sex ratio decreased with age (from 3.3:1 among 0-12
year olds, to 2.4:1 and 1.9:1 in teenagers and adults, respectively). This was
particularly evident for ASD without comorbid ID.
 ASD with ID was significantly more prevalent among 2nd generation immigrants
(implying that a Swedish-born individual’s mother was born abroad), compared to
individuals born in Sweden and 1st generation immigrants (implying that the
individual was born abroad).
 ASD without ID was significantly less prevalent among 2nd generation immigrants
from countries with a low human developmental index, and 1st generation
immigrants, compared to individuals born in Sweden and 2nd generation immigrants
from countries with a high human developmental index
 The prevalence of ASD overall - and particularly ASD with ID- decreased with
increasing familial levels of income
 ASD prevalence decreased with increasing level of parental education, regardless of
comorbid ID.
The key findings on changes in ASD prevalence among 0-17 year olds between 2001 and
2011 were as follows:
 ASD prevalence increased almost 3.5 fold among children aged 2-17 years. The
increase was mainly accounted for by an approximately 8-fold increase of ASD
without ID (from 1.4/ 1000 to 11.0/ 1000), while the prevalence of ASD with ID
increased only slightly (from 2.8/ 1000 to 3.4 /1000).
 A consistent increase of ASD without, but not with, ID was observed with subsequent
(younger) birth cohorts (Fig. 3 A, B). The occurrence of diagnosed ASD did not
appear to level off with increasing age within birth cohorts, regardless of ID (Fig. 3
A, B).
 Increases in ASD prevalence across birth cohorts were more prominent with
increasing age. For example, among 8, 14 and 16-year olds, ASD prevalence
increased approximately three, four and sixfold.
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 The proportion of ASD cases without ID steadily increased; from 21.7 to 80.6%
among 8-year olds, from 45.8 to 75.8 % among 14-year olds and from 33.3 to 74.3 %
among 16-year olds.
 No significant differences in changes of ASD prevalence with and without ID were
observed across birth cohorts in relation to sex, country of origin, and parental
education.
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A.
B.
Fig. 3 Prevalence of ASD with (A) and without ID (B) among 2–17 year olds in the Stockholm
Youth Cohort in 2001–2011, by age and birth cohort. Note: Although birth cohorts from 1990 to 2009 are
displayed, only certain cohort curves are labelled due to overlapping curves.
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4.3 STUDY III: PARENTAL AGE AND RISK OF OFFSPRING ASD
A total of 4,746 cases of ASD (of whom 42% had comorbid ID, n= 1,994) were found in the
study population (N=417,303).
The key findings of study III were as follows:
 Both higher maternal and paternal age increased the risk of ASD in offspring. While
maternal age effects were non-linear with increased risk beyond 30 years (OR 1.07;
95% CI 1.04-1.11 for mothers aged 30-34 years and OR 1.75, 95% CI 1.63-1.89 for
mothers aged 40-45 years compared to median maternal age of 29 years), paternal age
effects were linear (OR 0.9, 95% CI 0.90-0.96 for fathers aged 25-28 years and OR
1.14, 95% CI 1.10-1.18 for fathers aged 40-44 years compared to a median paternal
age of 32 years).
 The absolute risk of ASD was greater for older mothers as compared to older fathers,
e.g. mothers aged 40-45 years had an estimated 18.63 (95% CI 17.25-20.01) ASD
cases per 1,000 births whereas fathers aged 55-59 years had 16.35 (95% CI 15.11-
17.58) ASD cases per 1,000 births.
 In analyses stratified by co-parental age, increased risk of offspring ASD due to
advancing paternal age was only seen in mothers aged 35 years or younger. In
contrast, higher maternal age increased the risk off offspring ASD regardless of
paternal age.
 Advancing parental age was more strongly associated with ASD with, than without,
comorbid ID.
4.4 STUDY IV: MATERNAL BMI, GESTATIONAL WEIGHT GAIN AND RISK OF
OFFSPRING ASD
A total of 6420 cases of ASD were found in the study population consisting of 333,057
individuals aged 4-27 years, born to 176 850 mothers. The key findings were as follows:
 In the population-level analysis, maternal overweight and obesity were associated
with a greater ASD risk (OR25≤BMI<30 1.31, 95% CI 1.21-1.41; ORBMI≥30 1.94; 1.72-
2.17), as were paternal underweight and obesity (ORBMI<18.5 1.19, 95% CI 1.06-1.33;
ORBMI≥30 1.47; 1.12-1.92)
 In a matched sibling analysis, the association between maternal overweight/ obesity
and ASD risk was not evident
 In both population-level and matched sibling analyses, GWG was found to have a U-
shaped association with offspring ASD risk (ORinsufficient GWG 1.26; 1.10-1.43;
ORexcessive GWG 1.22; 1.08-1.43 and ORinsufficient GWG 1.26; 0.78-2.03; ORexcessive GWG
1.58; 1.00-2.48, respectively)
 Similar associations were observed regardless of ID
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5 DISCUSSION
5.1 KEY FINDINGS IN RELATION TO CURRENT KNOWLEDGE
5.1.1 Case definition
The ASD DSM-IV and ICD-10 diagnostic categories could not be employed in the studies
included in the present thesis because they were not recorded in all the registers from which
case ascertainment was drawn. However, as mentioned in the Introduction, the boundaries
between these diagnostic subtypes are not considered reliable (12-14). While our ability to
make comparisons with other studies that report these diagnostic categories is limited, our
strategy of subtyping ASD according to comorbid ID is more consistent with the DSM-5, the
most recent DSM revision which uses ID as a specifier (3).
5.1.2 Case identification
Our approach was to identify previously diagnosed cases in the SYC. In general, this strategy
is more likely to under-ascertain the prevalence among individuals not identified by services,
and the lowest ASD prevalence rates have been reported by epidemiological studies using
this strategy (45). However, we found that in both 2007 and 2011, the ASD prevalence in
studies I and II, respectively, corresponded to ASD prevalence estimates among comparable
age groups from large epidemiological studies based on active population screening and
subsequent diagnostic tests from the US (31, 33, 135), the UK (19, 23) and South Korea (20).
Factors likely to contribute to this result are described below.
Health care service systems in Stockholm are general, well-developed and free of charge for
children. All children are offered regular surveillance of social, motor, language and
cognitive development at child healthcare centres (124). Furthermore, there are regional
guidelines for diagnostic evaluation of neurodevelopmental disorders, and our validation
study (study I) confirmed that a majority of diagnostic evaluations had been performed in line
with these guidelines (126). While similar free healthcare services for children also exist in
other parts of Sweden as well as in the UK, Norway, Denmark, and Finland, recent studies
from these countries have reported lower ASD estimates in comparable age groups (40, 136,
137) than the SYC. A reason might be that the studies in question were only based on case
identification from medical registers, illustrating the advantage of the multisource case
identification strategy employed in the SYC. However, as previous studies suggest that a
substantial proportion of ASD cases remain unidentified (23, 33) ASD prevalence estimates
based on cases identified in the SYC should be considered conservative.
5.1.3 Validation of ASD case ascertainment
The clinical case-note review revealed that 96.0% of the scrutinized case notes were
consistent with a diagnosis of ASD, which is in line from other case-note reviews from the
UK (47) and Denmark (48). In our clinical case-note review, a lower proportion of ASD
cases with than without ID was confirmed. However, it is possible that children with ASD
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and severe ID did not undergo the structured intelligence tests required as part of the ASD
subtype confirmation in the validation study.
In the clinical case-note review, it was not possible to investigate whether the original source
of information (i.e. the clinical case notes) was in fact representative of a diagnosis of ASD.
Individual clinical evaluation by means of standardized, validated diagnostic instruments was
used to confirm 94% of ASD cases identified in the Norwegian Patient Register (40).
Alternatively, a standardized diagnostic interview with parents or caregivers was conducted
to confirm 96% of identified cases of childhood autism from the Finnish Hospital Discharge
Register (46). However, results from these studies are limited by small sample size and low
participation rate. Although measures such as data abstraction and calculation of inter-rater
reliability were undertaken in the present clinical case-note review to make the data
abstraction from case notes more objective, the subjectivity of the original recording
clinicians is still evident. Moreover, there is a possibility that when abstracting data,
researchers may be biased towards obtaining data in support of a diagnosis. In contrast, cross-
validation against the CATSS relied on parental interviews. Besides generating a high ASD
confirmation rate (85.2%), this approach also provided evidence that very few non-case twins
in the SYC received an ASD diagnosis in the CATSS. However, a drawback was the small
number of individuals eligible for cross-validation and that no cross-validation according to
comorbid ID could be made. Nevertheless, in combination, the two validation approaches
used in study I indicate high sensitivity and specificity of the ASD case ascertainment in the
SYC.
5.1.4 Current ASD prevalence
As discussed above, the universal healthcare system in Sweden and the thorough, multisource
case identification approach provided up to date ASD prevalence estimates in the SYC
comparable to studies comprising general population screening procedures. For example, the
overall 1.5% prevalence of ASD among 8-year olds from the 2010 surveillance in the US
(33), based on active screening and diagnostic evaluations in populations with identified
special education needs, symptoms associated with ASD or comorbid conditions, is
comparable to the 1.6% ASD prevalence among 8-year olds in 2011 in the SYC. In a study
from South Korea, a multistage approach including screening of a general population sample
yielded the highest ASD prevalence estimate to date, 2.6% among 6-12 year olds (20), which
is similar to ASD prevalence estimates among teenagers in the SYC.
Some studies using a multistage case ascertainment approach reported a higher proportion of
ASD cases with ID (19, 25, 33) than our study. However, in the general population sample of
a recent study from South Korea, an even lower proportion of cases with ID were identified,
indicating that ASD cases with a normal IQ are likely to remain unidentified.
5.1.4.1 Current ASD prevalence by socio-demographic characteristics
The most recent overall male: female ASD prevalence ratio of 2.3:1 among children and
young adults in the SYC is lower than the commonly reported 4:1 ratio (50). Furthermore,
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there was no difference between the male: female ratio in terms of comorbid ID, in contrast
to previous epidemiological studies reporting a lower male: female ratio with an increasing
proportion of ID (50). Results from several recent epidemiological studies using a multistage
ascertainment approach were in line with the male: female ASD prevalence ratio observed in
comparable age groups in the SYC (19, 20, 25, 51), while two Japanese studies reported an
even lower ratio (25, 138). Although biological mechanisms may contribute to the sex
differences in prevalence (52), our findings from the case-note review indicate that later
diagnosis of ASD in girls likely contributes to the comparatively lower male: female ratio in
ASD prevalence observed in our studies. In other words, it is likely that young girls with
ASD are under-ascertained in the SYC.
Besides young girls, other groups are likely to be under-ascertained in the SYC, despite
advantages of the free and universal health care offered to child residents in Stockholm.
Differences in access to healthcare may contribute to the lower prevalence of ASD without
ID among individuals with a migrant background from developing countries previously
reported in Sweden (63, 139) and the Netherlands (140) - a finding also observed in the SYC.
In contrast, ASD was found to be significantly more prevalent among 2nd generation
immigrants in the SYC, a finding which may be affected by factors associated with migration
(63). Under-ascertainment among pre-school children with ASD is probable, as indicated by
the high median age at diagnostic evaluation found in the clinical case-note review (study I).
Considering that children can be reliably diagnosed with ASD by 2 years of age (4, 5) and the
potential benefits of early intervention at the individual (7, 8) and familiar/ societal level
(141, 142), a median age of 8 year at diagnosis is alarmingly high. Compared to the SYC,
studies from Sweden (26) and Japan (25) in which active ASD screening procedures were
applied reported substantially higher ASD prevalence estimates of 0.8% and 1.8% among 2
year olds and preschool children, respectively. Finally, prevalence estimates in our adult
population may have been underestimated due to truncation, i.e., key registers for case
identification being started in 1997 and 2001, respectively. However, the most recent estimate
of a 1.8% ASD prevalence among 18-27 year olds in the SYC is higher than the 1%
identified in a UK adult population (35).
A socio-economic gradient in ASD prevalence was found in the SYC, in that higher
prevalence corresponded with lower familial levels of income and parental education. In
contrast, US studies report an association between offspring ASD and higher parental socio-
economic status (53-57), while our findings are in agreement with studies from countries with
universal healthcare systems (58-62). Together with our results, the latter findings indicate
that when disparities in access to healthcare are minimized, the observed socio-economic
gradient resembles previously observed associations between low parental socio-economic
status and negative developmental outcomes in children (143, 144).
5.1.5 Recent changes in ASD prevalence
The recent increase in ASD prevalence observed in the SYC is paralleled by findings from
the US (33, 145), Canada (64), Iceland (11), Denmark, Finland, Sweden, Western Australia
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(136) and Japan (25). According to a recent review, ASD prevalence increases have become
more pronounced for cases without ID, which is also in line with our findings from SYC (49).
In fact, the prevalence of ASD with ID increased only marginally between 2001 and 2011 in
the SYC. In contrast to the U.S. where improved ASD identification in specific ethnic
subgroups was noted over time (33), no significant differences in ASD prevalence with and
without ID were observed across birth cohorts in relation to sex, country of origin or parental
education.
Which factors drive the substantial increase of identified ASD without ID in the SYC?
Identical case ascertainment methodology was applied throughout the study period, thus, the
increase in ASD prevalence is unlikely explained by changes in internal measurement. Nor
were the diagnostic boundaries of ASD widened during the study period, which would
contribute to increasing ASD prevalence. However, there were regional changes in the
healthcare services leading to enhanced detection, which are likely to have contributed to the
largest proportion of the ASD prevalence increase. Specifically, the considerably increased
rate of diagnostic evaluations between 2007-2011 among children in Stockholm County
(146) may have contributed to identification of ASD cases without ID, which are generally
less likely to be detected by healthcare, educational and social support services than cases
with ID (20). This is supported by the pronounced ASD prevalence increase in the older age
groups in the SYC, as a substantially higher median age at diagnosis was found for ASD
cases without compared to with ID in the case-note review in study I. It has been speculated
in previous studies (6, 147) that the younger age at ASD diagnoses in recent years has
contributed to increased ASD prevalence (39, 68, 148, 149), a factor that is unfortunately not
possible to examine empirically in the SYC. There may also be a growing acceptance that
ASD can co-exist with other conditions such as attention deficit/hyperactivity disorder or
learning disabilities. In fact, it has been hypothesized that comorbid conditions with autistic
features are increasingly diagnosed as ASD, contributing to the recent increase in ASD
prevalence (150). A reason for this may be that in Sweden, a diagnosis of ASD is more likely
to result in school and community support, than other diagnoses.
Collectively, this evidence points to factors related to identification as the primary driver of
the increased prevalence of ASD without ID in the SYC. In a recent multi-national study
(136) it was speculated that similar mechanisms underlie recent prevalence increases of other
neuropsychiatric disorders besides ASD. However, a true increase in ASD incidence cannot
be ruled out. Similarly, a considerable share of the increase of ASD prevalence in Denmark
could not be explained by factors related to improved identification (67), emphasizing the
need for further exploration of aetiological factors that potentially contribute to the increased
prevalence.
5.1.6 Parental age and risk of offspring ASD
Our finding that higher maternal and paternal age increases the risk of ASD in offspring is in
line with results from previous meta-analyses (81, 82). However, there was variation in the
shape of maternal and paternal age effects on ASD risk, indicating that different mechanisms
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may underlie these effects. While paternal age effects were linear, we found a non-linear
maternal age effect, which increased sharply after the maternal age of 30 years. Moreover, the
paternal age effect on offspring ASD risk was only evident in mothers aged 35 years or
younger, which is in line with two previous studies (94, 151). In contrast, higher maternal age
increased the risk of ASD in offspring ASD, irrespective of paternal age. When combined,
these findings may indicate that paternal age effects are evident among younger women who
are at less risk of obstetrical complications (84). The linear paternal age effects on offspring
ASD risk found in the SYC resemble the linear increase in de novo mutations with increasing
paternal age observed in recent family-based studies (152, 153), thus supporting the
hypothesis of age-related mutagenesis of male germ cells as the underlying mechanism.
When the risks of perinatal and obstetric complications – or some other age-related risk -
increase among mothers older than 35 years, they may overpower paternal age effects.
Although much recent research attention has focused on paternal age effects on offspring
ASD risk (80), our study indicates that attention also needs to be devoted to potential
mechanisms and moderating factors of maternal age effects.
We found higher parental age to be more strongly associated with ASD with as opposed to
without ID. This may be due to previously demonstrated associations between decreased
offspring intelligence and advanced maternal (154, 155) and paternal (154, 156) age,
although results are inconsistent. Direct comparison with other studies is difficult due to small
samples in some studies as well as presentation of results based on the ICD / DSM
classification of ASD.
5.1.7 Maternal BMI, gestational weight gain and risk of offspring ASD
In line with previous studies (58, 102), an association was found between maternal pre-
pregnancy obesity and offspring ASD risk at the population-level analysis of the SYC.
Maternal obesity at age 18, although not for the period closer to pregnancy, was related to
offspring ASD in a US study of nurses (103). Moreover, the effect size of the association
reported by these studies is in line with the effect size found in the population-level analysis
of the SYC.
However, further findings in our study indicate that the association between maternal pre-
pregnancy overweight and offspring ASD may be ascribed to unmeasured familiar
confounding. First, we found that paternal underweight and obesity were associated with
increased risk of offspring ASD, which suggests a contribution of genetic factors to the
relationship between parental BMI and offspring ASD. A link between paternal obesity and
certain diagnostic subtypes of ASD was recently found in a Norwegian study. However,
interpretations of the latter result may be limited due to the self-reported exposure data, and
substantial under-ascertainment of ASD cases (108). Moreover, no relationship with maternal
overweight or obesity was found in the sibling analysis in the SYC, further suggesting that
this association may be ascribed to unmeasured familial confounders.
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Excess GWG was associated with offspring ASD risk in the population level analysis of the
SYC, which is in line with previous reports (58, 104). Moreover, excess GWG was also
associated with offspring ASD in the sibling analysis, which agrees with the results of a
previous study with a substantially smaller sample size (104). Although caution is required
when interpreting the findings due to the wide 95% CI in the sibling analysis, our study is the
first to report an increased risk of offspring ASD associated by insufficient weight gain
during pregnancy. The latter indicates the possibility that maternal under-nutrition during
pregnancy may contribute to ASD risk.
5.2 METHODOLOGICAL CONSIDERATIONS
5.2.1 Study design
The most powerful way to study risk factors is to conduct a randomized controlled trial in
which the researcher selects risk factors of interest and applies them to study groups that are
otherwise similar in their susceptibility to a disease. However, an experimental study design
is seldom considered ethically justifiable in human research as well as taking a long time and
being very expensive. Therefore, most epidemiological studies of risk factors are
observational, meaning that the researcher observes events in relation to exposure, rather than
actively assigning individuals to different exposures of interest. A problem with observational
studies is that individuals who are exposed to a risk factor of interest differ from unexposed
individuals in terms of factors other than the exposure itself. This makes it difficult to infer
whether outcomes in exposed and unexposed groups differ due to exposure to the risk factor
of interest, or other factors. In other words, differences between exposed and unexposed
individuals can confound the association between the risk factor and outcome. While
confounding can be minimized in an experimental study, they need to be carefully accounted
for in observational studies.
As a total population study with prospective data collection, the SYC provides an opportunity
to study a range of risk factors and outcomes using extensive register-based data not only on
the index population but also on their relatives. Such a study also enables calculation of
absolute risk, for example, the risk of offspring ASD in various maternal and paternal age
groups in study III. The SYC also permits cross-sectional examination of outcomes, such as
ASD prevalence at selected time points (studies I and II), which is of public health interest for
the allocation and planning of resources. The largest drawback of the register based study
design is that only those exposures, outcomes and covariates available in the registers can be
examined. Although the registers provide a wide range of individual and contextual level data
of very high quality and completeness, they are designed for administrative purposes and do
not necessarily provide data that suit the research questions focused upon. However, the
alternative approach of prospectively collecting data specifically adapted for the research
questions would require extensive resources and time.
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5.2.2 Random error
Random errors result from chance findings. As described in the Methods section, they are
described by confidence intervals and p-values. The risk of random errors in large
epidemiological studies is small, because it is reduced with increasing sample size. However,
the confidence intervals in the sibling comparison in study IV were wide, indicating greater
uncertainty about the results.
5.2.3 Systematic error
Ideally, study populations are similar to the target populations they make inferences about,
which implies high applicability or external validity of the results. Furthermore, in ideal
conditions the characteristics of exposed and non-exposed groups are identical, apart from the
exposure. However, most studies are biased as a result of systematic errors in the study
design, which can involve selection of the study sample (selection bias) and how information
is obtained or classified (misclassification bias). These two types of bias can be addressed at
the planning stage of a study but not controlled in the analytical stage. The association
between an exposure and an outcome can also be affected by the presence of another
variable, i.e., mixing or confounding of the effects. In contrast to selection and
misclassification bias, confounders can be controlled for in the analytical stage of a study.
5.2.3.1 Selection bias
Selection bias occurs if the association between an exposure and outcome differs for cases in
the study when compared to cases who do not participate in the study. In general, selection
bias in the SYC is minimized by the virtually complete coverage of the total population
through mandatory registers. Furthermore, the majority of diagnosed ASD cases are likely to
have been captured in the SYC due to case identification from multiple sources.
Selection bias can also result from missing data for variables, which may lead to exclusion of
individuals from the study. Although the completeness of the SYC registers is generally high,
adopted children were excluded in studies III and IV as exposure data were not available for
them. For similar reasons, children born outside Sweden and from multiple births were
excluded in study IV. There was limited availability of exposure data (parental BMI and
GWG) in study IV; for example, maternal weight at time of delivery, which enables
calculation of GWG, was only available for 34% of the study population. However, no
notable differences were found between women with and without BMI and GWG data in the
eligible population. This suggests that BMI data were missing at random and thus did not
introduce selection bias into the results.
In study IV it was found that fathers for whom BMI data were available were less likely to be
immigrants and to have a child with a mother of immigrant origin. However, these factors
were adjusted for in the multivariate analyses and are unlikely to have influenced the internal
validity of the study.
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5.2.3.2 Misclassification bias
This type of bias results when recorded information about exposure and/ or outcome in the
study participants is incorrect. Misclassification bias can be non-differential, implying that it
is equally likely to occur in both study groups (e.g. exposed and non-exposed), which results
in an underestimate of the true association. It can also be differential, implying that it occurs
to a greater extent in one study group than the other (i.e., exposed or non-exposed
individuals). Differential misclassification results in either an underestimate of the true
associations, or false positive findings.
Exposure misclassification
By using prospectively collected data, the risk of recall bias in relation to exposure status is
avoided in the SYC. The accuracy of maternal age is considered high in the MGR, which was
used as a data source. In the MGR, the biological father of a child is assumed to be the
husband of the mother at time of birth or is identified by acknowledgement by unwed
mothers. However, the accuracy of paternity in the MGR has not been examined, implying a
theoretical possibility of misclassification regarding paternal age in study II.
Outcome misclassification
Although most diagnosed ASD cases are likely to have been captured by the multisource case
ascertainment methodology, there is a possibility of undiagnosed cases among individuals not
registered as having ASD in the SYC (i.e., false negatives). As previously discussed, there is
risk of outcome misclassification among young children, adults, and individuals of immigrant
background. Similarly, some misclassification of outcome status with regard to exposure may
be possible in the SYC despite a universal health care system for children and thorough data
collection. For example, it may be so that identification of ASD in a child is influenced by
parental age.
To maximize the likelihood of an affected individual being registered with a diagnosis of
ASD, and hence minimize outcome misclassification, in studies I, III, and IV we restricted
the population to individuals who were resident in Stockholm County for at least 4 years.
However, because we wished to estimate the prevalence of ASD among children under 4
years, we did not include this restriction in study II.
In study I, we assessed the extent to which the outcome variable ASD with and without ID
corresponded with an accurate data entry into the SYC. Because case-note reviews may be
biased by the subjectivity of the originally recording clinicians well as abstracters being more
likely to abstract data in favour of confirming a diagnosis, outcome misclassification was
assessed by cross-validation against the CATSS. However, since outcome misclassification
cannot be ruled out, findings from the SYC should be interpreted bearing this potential bias in
mind. However, outcome misclassification is likely to affect both exposed and unexposed
groups in the same way, and thus lead to underestimations of associations rather than false
positive findings.
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5.2.3.3 Confounding
Confounding may distort the association focused upon in a study. Confounding variables are
determinants of both the outcome and exposure, in addition to constituting an important
source of bias in epidemiological studies. There are several methods for addressing
confounding. In the population-based analyses in studies III and IV, a range of confounders
were chosen à priori based on reported associations with ASD (62, 63, 106), and adjusted for
in multivariable regression models. However, residual confounding due to factors that are
unknown, or unavailable from the data, is still possible. Most important, it is difficult to
address confounding caused by genetic factors in register-based studies such as the SYC
because the data do not include a diagnosis of ASD or related traits in relatives of the study
population.
Two different family study approaches were used in study IV in order to better address
confounding by unmeasured familial factors. First, the association between both maternal and
paternal BMI and offspring ASD was examined, to test the hypothesis that stronger
associations for maternal, than paternal BMI would be indicative of causal intrauterine
mechanisms. While exposure data in the SYC is prospectively collected and paternal
conscription BMI data are considered of high quality (157), no paternal BMI data were
available for the period closer to the birth of the child. However, an advantage of using
conscript BMI data is that factors that increase with paternal age and might confound the
association between paternal BMI and offspring ASD are unlikely to be introduced into the
model. In other words, using paternal BMI data from a period long before the birth may be
better for testing the hypothesis that genetic factors underlie the association between parental
BMI and offspring ASD. Second, a sibling comparison analysis was used to control for both
genetic and environmental characteristics shared by siblings. However, sibling comparison
estimates are more severely biased by non-shared confounders such as birth order and
parental age, than standard comparisons (158). Although non-shared confounders such as sex,
birth year, sibling birth order, and maternal and paternal age at the time of birth were adjusted
for in our sibling analysis, there might be residual non-shared confounders among offspring
of women whose weight changes substantially between pregnancies.
5.2.4 Power
Because the SYC is a large total population study, relatively rare exposures and outcomes can
be examined with sufficient power (i.e., the ability of a study to find a true difference).
However, the population size is reduced in the sibling analysis in study IV, which weakens its
power.
5.2.5 External validity / generalizability
This thesis comprises population studies based on regional and national registers. It should be
noted that the multisource ASD case ascertainment used in the SYC only applies to
Stockholm County. Therefore, the prevalence estimates of diagnosed ASD found in the SYC
may not pertain to other parts of Sweden, unless similar services are available or targeted
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ASD screening is applied. When such screening was carried out at child healthcare centres in
the Swedish city of Gothenburg, it resulted in even higher ASD prevalence estimates among
toddlers than in the SYC (26). Furthermore, similar proportions of ASD cases in comparable
age groups were found in recent studies in several developed countries using combined
population screening and diagnostic procedures (20, 33, 135, 159). Interestingly, results from
other studies using these procedures were also similar to our results concerning the
proportion of ASD cases with comorbid ID (33) and the male: female ratio (20, 25). Taken
together, these results demonstrate that the proportion of children with ASD in the SYC is
in line with studies from other countries in which thorough, multistage case ascertainment
methodology was employed, indicating that studies on ASD from the SYC are likely to
have good external validity and that the results can thus be generalized to other developed
countries.
The limited availability of parental BMI and GWG data potentially limits the generalizability
of the study IV, despite the fact that measures were undertaken to maximize the internal
validity of the findings. Furthermore, the sample used in the sibling analysis may produce
biased results that limit generalizability, because only certain kinds of families can be
included by this design.
49
6 CONCLUDING REMARKS AND FUTURE DIRECTIONS
Data from Swedish national and regional registers indicate a substantial increase in the
prevalence of identified ASD cases without comorbid ID in Stockholm over recent years. At
present, more individuals are affected by ASD than was previously believed to be the case,
with more than 2% of teenagers registered with ASD. While findings from Stockholm
suggest that factors related to improved identification of ASD are likely to have contributed
to the observed increase in ASD prevalence, an actual increase in ASD cannot be ruled out,
emphasizing the need for further exploration of risk factors that potentially contribute to the
increased prevalence.
Is it possible to attribute any of the ASD prevalence increase to current trends of deferred
parenthood, maternal obesity or other non-genetic risk factors? While higher parental age
does increase the ASD risk by a yet unknown mechanism, its contribution to the increase in
ASD prevalence has been estimated as small (94). Due to methodological limitations, we
cannot rule out an association between maternal pre-pregnancy overweight and offspring
ASD risk. However, results from our study indicate that this association may be confounded
by familiar factors, which needs to be examined further using other study designs. While
observed changes in pre, peri, and neonatal risk factors for ASD over time may theoretically
contribute to increased ASD prevalence, their impact has been estimated as minimal (160).
Similarly, in a study conducted in California, broad environmental factors and younger age at
diagnosis were less likely to explain age, period and cohort effects than changes in diagnostic
practices and increased awareness (161). However, empirically identifying and quantifying
factors that contribute to changes in ASD prevalence is challenging as these factors are likely
to be multiple and overlapping.
Despite the challenges involved in identifying the causes of increasing ASD prevalence,
recent changes in identified prevalence of ASD with ID are not unique to Stockholm and
highlight the importance of providing adequate services. It is hypothesized that recent
increases in ASD prevalence are a result of a greater tendency to diagnose comorbid
conditions with autistic features as ASD (150), possibly because such a diagnosis enables
more extensive support at school or in the community. Nevertheless, affected individuals
need support adapted to their specific symptom presentation. It is important to bear in mind
that ASD are generally life-long conditions, thus population-based, longitudinal studies
related to various outcomes of ASD among adults are required for service planning (17).
Results from studies included in this thesis as well as other studies from the SYC suggest that
subtyping of ASD by ID is useful, as epidemiological and genetic evidence indicates that
different aetiological mechanisms may underlie these subtypes (15, 18). However, additional
methods of subtyping should be employed in future studies to better represent the phenotypic
variability of ASD. Future studies may have an advantage in the subtyping of ASD, because
the DSM 5 allows comorbidity unlike the DSM IV and ICD 10.
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Although the advantages of the general Swedish healthcare system and the thorough case
ascertainment design used in our study provide ASD prevalence estimates comparable to
more detailed studies that also include general population screening procedures, there are
indications that ASD is currently under-ascertained among girls, preschool children, adults
and individuals of immigrant background. Further studies of potential aetiological
implications that contribute to differences in prevalence among girls and individuals of
migrant background are also warranted. More importantly, because diagnostic barriers may
delay intervention, it is important to examine impact of factors determining timely
identification of children with developmental problems.
7 CONCLUSIONS
The prevalence of identified ASD without comorbid ID has increased substantially between
2001 and 2011 in Stockholm County, and ASD currently affects more than 2% of teenagers,
with important implications for the planning of health and educational services. Changes in
diagnostic practice and awareness are likely to be the main drivers of the rise, but an actual
true increase in ASD incidence cannot be ruled out.
As ASD implies a considerable burden for the individual, family and society, it is important
to identify potentially modifiable risk factors. Our study on parental age and ASD suggests
that both maternal and paternal age increase the risk of offspring ASD, possibly through
different mechanisms. Nevertheless, the absolute risk of offspring ASD with higher parental
age is modest and probably does not contribute vastly to the observed increase in ASD
prevalence. The family study approaches we used to investigate the relationship between
maternal overweight and offspring ASD risk suggest that this association may be ascribed to
unmeasured familial confounding. In addition, evidence of a too small or large weight gain
during pregnancy increasing ASD risk in offspring was found. These findings need to be
examined further in further studies.
The prevalence of ASD, its changes over time and the magnitude of parental age effects on
risk of offspring ASD varied according to comorbid ID, emphasizing the value of subtyping
ASD according to ID. Finally, the SYC, with its extensive data from Swedish registers as
well as valid and thorough ASD case ascertainment constitutes an important resource for
ASD research.
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